TransMedics Group (TMDX) Shares Down 60% From Class Period High, Class-Action Suit Pending – Hagens Berman
Portfolio Pulse from
TransMedics Group (TMDX) is confronting a class-action lawsuit filed by Hagens Berman, alleging fraudulent billing practices, safety issue concealment, and anti-competitive business conduct. The lawsuit covers the period from February 28, 2023, to January 10, 2025, and was triggered by a Congressional letter and a critical report from Scorpion Capital.
March 28, 2025 | 6:00 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
The class-action lawsuit alleges serious misconduct including fraudulent billing, safety issue concealment, and anti-competitive practices, which could substantially impact the company's financial and operational standing.
The lawsuit presents multiple serious allegations that could lead to significant financial penalties, regulatory investigations, and long-term reputational damage for TransMedics Group.
CONFIDENCE 90
IMPORTANCE 95
RELEVANCE 100